Results 161 to 170 of about 1,822 (274)

Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML

open access: yes
American Journal of Hematology, Volume 100, Issue 10, Page 1853-1858, October 2025.
Nia Choi   +11 more
wiley   +1 more source

Gene and RNA Editing: Revolutionary Approaches to Treating Diseases

open access: yesMedComm, Volume 6, Issue 10, October 2025.
The image illustrates gene editing technologies: DNA editing using CRISPR–Cas9 and RNA editing via Cas13d, with their clinical applications and ethical risks. DNA editing allows precise gene modifications for conditions like amyotrophic lateral sclerosis [ALS] and Huntington's disease, while RNA editing supports multiplexed modifications.
Jia‐Mei Li   +6 more
wiley   +1 more source

Longitudinal data collection in pediatric and adult patients with 5q spinal muscular atrophy in Latin America: LATAM RegistrAME study - a clinical registry study protocol. [PDF]

open access: yesEinstein (Sao Paulo)
Batista EC   +7 more
europepmc   +1 more source

Sensory dysfunction in SMA type 2 and 3 - adaptive mechanism or concomitant target of damage? [PDF]

open access: yesOrphanet J Rare Dis
Koszewicz M   +4 more
europepmc   +1 more source

Motor Unit Number Index (MUNIX) in Control Children: Reference Values and Reliability

open access: yesMuscle &Nerve, Volume 72, Issue 4, Page 625-631, October 2025.
ABSTRACT Introduction/Aims The motor unit number index (MUNIX) is recognized as a reliable electrophysiological biomarker, and reference values are available for healthy adults but not for children. The aim of this study was to determine reference MUNIX values in healthy children.
Christophe Boulay   +7 more
wiley   +1 more source

Clinical Utility of Far‐Field Potentials in Amyotrophic Lateral Sclerosis

open access: yesMuscle &Nerve, Volume 72, Issue 4, Page 616-624, October 2025.
ABSTRACT Introduction/Aims Far field potentials (FFP) have been proposed as a reliable neurophysiological prognostic biomarker in amyotrophic lateral sclerosis (ALS). This study evaluates the diagnostic utility of ulnar nerve FFP in ALS. Methods Comprehensive peripheral neurophysiological assessments were conducted in 62 ALS and 43 ALS‐mimicking ...
Aicee Dawn Calma   +7 more
wiley   +1 more source

Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy. [PDF]

open access: yesBrain Behav
Bahadır Şenol H   +6 more
europepmc   +1 more source

Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1.

open access: yesJAMA Netw Open
Ropars J   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy